Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Elsa, Diguet"'
Autor:
Noémie Cresto, Marie-Claude Gaillard, Camille Gardier, Francesco Gubinelli, Elsa Diguet, Déborah Bellet, Laurine Legroux, Julien Mitja, Gwenaëlle Auregan, Martine Guillermier, Charlène Josephine, Caroline Jan, Noëlle Dufour, Alain Joliot, Philippe Hantraye, Gilles Bonvento, Nicole Déglon, Alexis-Pierre Bemelmans, Karine Cambon, Géraldine Liot, Emmanuel Brouillet
Publikováno v:
Neurobiology of Disease, Vol 134, Iss , Pp - (2020)
The G2019S substitution in the kinase domain of LRRK2 (LRRK2G2019S) is the most prevalent mutation associated with Parkinson's disease (PD). Neurotoxic effects of LRRK2G2019S are thought to result from an increase in its kinase activity as compared t
Externí odkaz:
https://doaj.org/article/f99d8776c12c4a7bb6880f866319890e
Autor:
Elsa Diguet, Pierre-Olivier Fernagut, Elisabeth Normand, Laurie Centelles, Christophe Mulle, François Tison
Publikováno v:
Neurobiology of Disease, Vol 15, Iss 3, Pp 667-675 (2004)
Age of onset of Huntington's disease (HD) statistically correlates with the length of expanded CAG repeats in the IT15 gene. However, other factors such as polymorphism in the 3′ untranslated region of the GluR6 kainate receptor gene subunit may co
Externí odkaz:
https://doaj.org/article/89cb3264aaab48938d21ace22b1f1d57
Autor:
Martine Guillermier, Marie-Claude Gaillard, Géraldine Liot, Déborah Bellet, Gwenaëlle Auregan, Elsa Diguet, Nicole Déglon, Noelle Dufour, Philippe Hantraye, Francesco Gubinelli, Julien Mitja, Karine Cambon, Noémie Cresto, Emmanuel Brouillet, Charlène Joséphine, Alain Joliot, Camille Gardier, Caroline Jan, Gilles Bonvento, Laurine Legroux, Alexis-Pierre Bemelmans
Publikováno v:
Neurobiology of Disease
Neurobiology of Disease, Elsevier, 2020, 134, pp.104614. ⟨10.1016/j.nbd.2019.104614⟩
Neurobiology of Disease, Vol 134, Iss, Pp-(2020)
Neurobiology of Disease, 2020, 134, pp.104614. ⟨10.1016/j.nbd.2019.104614⟩
Neurobiology of Disease, Elsevier, 2020, 134, pp.104614. ⟨10.1016/j.nbd.2019.104614⟩
Neurobiology of Disease, Vol 134, Iss, Pp-(2020)
Neurobiology of Disease, 2020, 134, pp.104614. ⟨10.1016/j.nbd.2019.104614⟩
International audience; The G2019S substitution in the kinase domain of LRRK2 (LRRK2 G2019S) is the most prevalent mutation associated with Parkinson's disease (PD). Neurotoxic effects of LRRK2 G2019S are thought to result from an increase in its kin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a24321246af441b617fd04891e482496
https://hal.archives-ouvertes.fr/hal-03043360/document
https://hal.archives-ouvertes.fr/hal-03043360/document
Autor:
Elsa Diguet, Fanny Petit, Carole Escartin, Karine Cambon, Nicolas Bizat, Noëlle Dufour, Philippe Hantraye, Nicole Déglon, Emmanuel Brouillet
Publikováno v:
PLoS ONE, Vol 4, Iss 2, p e4637 (2009)
Aging likely plays a role in neurodegenerative disorders. In Huntington's disease (HD), a disorder caused by an abnormal expansion of a polyglutamine tract in the protein huntingtin (Htt), the role of aging is unclear. For a given tract length, the p
Externí odkaz:
https://doaj.org/article/05c5333cf7b94ae0824b4acd577e12e4
Publikováno v:
Progress in brain research. 230
Stem cell-based therapy trials for the treatment of neurodegenerative diseases such as Parkinson's and Huntington's disease are being actively prepared both at the preclinical and clinical level. Preclinical validation of these stem cell transplantat
Stem cell-based therapy trials for the treatment of neurodegenerative diseases such as Parkinson's and Huntington's disease are being actively prepared both at the preclinical and clinical level. Preclinical validation of these stem cell transplantat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73197be3dc54a7acdd7c717fd3cbb4a5
https://doi.org/10.1016/bs.pbr.2016.11.001
https://doi.org/10.1016/bs.pbr.2016.11.001
Autor:
Philippe Hantraye, Bengt Mattsson, Shane Grealish, Elsa Diguet, Andreas Heuer, Malin Parmar, Agnete Kirkeby, Yann Bramoullé, Anselme L. Perrier, Nadja Van Camp, Anders Björklund
Publikováno v:
Cell Stem Cell
Cell Stem Cell; 15(5), pp 653-665 (2014)
Cell Stem Cell; 15(5), pp 653-665 (2014)
Summary Considerable progress has been made in generating fully functional and transplantable dopamine neurons from human embryonic stem cells (hESCs). Before these cells can be used for cell replacement therapy in Parkinson’s disease (PD), it is i
Autor:
Noelle Dufour, Philippe Hantraye, Elsa Diguet, Nicole Déglon, Alexandra Benchoua, Stan Krajewski, Jean-Marc Elalouf, Yaël Trioulier, Emmanuel Brouillet, Carole Malgorn, Marie-Claude Gaillard
Publikováno v:
Human Molecular Genetics
In neurodegenerative disorders associated with primary or secondary mitochondrial defects such as Huntington's disease (HD), cells of the striatum are particularly vulnerable to cell death, although the mechanisms by which this cell death is induced
Autor:
Gregor K. Wenning, François Tison, Zoe Puschban, Christoph Scherfler, Werner Poewe, Elsa Diguet, Nadia Stefanova, T. Sather
Publikováno v:
Journal of Neural Transmission. 112:1025-1033
We investigated neuroprotective effects of riluzole, an anti-glutamatergic agent that is FDA approved for disease-modifying therapy in amyotrophic lateral sclerosis (ALS), in an established double lesion rat model of striatonigral degeneration (SND),
Publikováno v:
Journal of Neural Transmission. 112:613-631
We investigated the potency of riluzole, an anti-glutamatergic drug, to affect ongoing neuronal death process following combined MPTP + 3-nitropropionic acid (3-NP) intoxication producing combined striatal and nigral degeneration (SND) in mice. We us